title: Vaccination of travelers: how far have we come and where are we going?
abstract: Vaccine recommendations are a prominent part of health preparations before international travel. We review progress made in the past decade regarding vaccines used primarily by persons traveling from high-income countries to low- and middle-income countries. The combined hepatitis A-B vaccine, the recently licensed Vero cell-derived Japanese encephalitis vaccine and conjugated quadrivalent meningococcal vaccines are discussed. This article provides updates on yellow fever vaccine-associated visceral and neurologic adverse events, indications for influenza vaccine in travelers, the rapid immunization schedule for tick-borne encephalitis vaccine, schedules for postexposure rabies prophylaxis, and new insights about oral cholera vaccines following the outbreak in Haiti. The future should bring vaccines for serogroup B Neiserria meningitidis, dengue and malaria, as well as an inactivated yellow fever vaccine.
authors: Mount Auburn Hospital, Cambridge, MA, USA. lchen@hms.harvard.edu
authors: Lin H
authors: LH
authors: Chen
authors: David R
authors: DR
authors: Hill
authors: Annelies
authors: A
authors: Wilder-Smith
mesh_terms: D001424:Bacterial Infections / Q000517:prevention & control; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D049674:History, 21st Century; D006801:Humans; D056990:Post-Exposure Prophylaxis / Q000379:methods; D014195:Travel; D057236:Travel Medicine / Q000266:history / Q000379:methods* / Q000639:trends; D014611:Vaccination / Q000266:history / Q000379:methods* / Q000639:trends; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D014777:Virus Diseases / Q000517:prevention & control
chemical_list: D001428:Bacterial Vaccines; D014765:Viral Vaccines